清脆的
核糖核酸
环介导等温扩增
2019年冠状病毒病(COVID-19)
计算生物学
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
基因组
生物
病毒学
分子生物学
DNA
基因
遗传学
医学
病理
传染病(医学专业)
疾病
作者
Kean Hean Ooi,Mengying Mandy Liu,Douglas Jie Wen Tay,Seok Yee Teo,Pornchai Kaewsapsak,Shengyang Jin,Chun Kiat Lee,Jingwen Hou,Sebastian Maurer‐Stroh,Weisi Lin,Benedict Yan,Gabriel Zherong Yan,Yong‐Gui Gao,Meng How Tan
标识
DOI:10.1038/s41467-021-21996-6
摘要
Extensive testing is essential to break the transmission of SARS-CoV-2, which causes the ongoing COVID-19 pandemic. Here, we present a CRISPR-based diagnostic assay that is robust to viral genome mutations and temperature, produces results fast, can be applied directly on nasopharyngeal (NP) specimens without RNA purification, and incorporates a human internal control within the same reaction. Specifically, we show that the use of an engineered AsCas12a enzyme enables detection of wildtype and mutated SARS-CoV-2 and allows us to perform the detection step with loop-mediated isothermal amplification (LAMP) at 60-65 °C. We also find that the use of hybrid DNA-RNA guides increases the rate of reaction, enabling our test to be completed within 30 minutes. Utilizing clinical samples from 72 patients with COVID-19 infection and 57 healthy individuals, we demonstrate that our test exhibits a specificity and positive predictive value of 100% with a sensitivity of 50 and 1000 copies per reaction (or 2 and 40 copies per microliter) for purified RNA samples and unpurified NP specimens respectively.
科研通智能强力驱动
Strongly Powered by AbleSci AI